X
07Aug

FDA Guidance ZIKV Testing Strategy Webinar

0 Comments | | Return |

On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to FDA Guidance on ZIKV Testing Strategy. Please register for CTS FDA Guidance ZIKV Testing Strategy Webinar by clicking the link: CTS FDA Guidance ZIKV Testing Strategy Webinar

Related

Join us for a Babesia webinar!

As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...

Read More >

Updated Sample Acceptability Document

CTS was recently notified that one of the tubes listed in the Sample Acceptability document...

Read More >

CTS to Implement Donor HLA testing on the Stratec Gemini Instrument

On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...

Read More >

Renewed NYSDOH licenses now available on the website

As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....

Read More >

CTS implements Ortho VIP Viral Marker Testing Platform

On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...

Read More >

Special Testing Laboratory Test Result Reporting Change

An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...

Read More >

Subscribe here to receive CTS updates!

Name